Kvartil Liquid Private Assets A vs UBS Lux Equity Fund Biotech USD

Kvartil Liquid Private Assets A vs UBS Lux Equity Fund Biotech USD

1. Kvartil Liquid Private Assets A

  • Security

    Kvartil Liquid Private Assets A

  • Fee

    1.50%

  • ISIN

    SE0019352485

  • Holdings

    13

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 14 holdings in Kvartil Liquid Private Assets A, where the largest holding is Investor (32.84), followed by Lundbergföretagen (14.26) and Kinnevik (10.3). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.9) and Moderna (9.21).

All Holdings

Here we compare the holdings in Kvartil Liquid Private Assets A and UBS Lux Equity Fund Biotech USD.

Kvartil Liquid Private Assets A UBS Lux Equity Fund Biotech USD
1. Investor B
Sweden
32.84 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Lundbergföretagen B
Sweden
14.26 %
2. Vertex Pharmaceuticals Inc
9.9 %
3. Kinnevik B
Sweden
10.3 %
3. Moderna Inc
9.21 %
4. Latour B
Sweden
10.19 %
4. Alnylam Pharmaceuticals Inc
6.54 %
5. Sampo Oyj A
Finland
9.33 %
5. AbbVie Inc
USA
5.52 %
6. Aker ASA
Norway
9.28 %
6. Gilead Sciences Inc
USA
4.66 %
7. Groupe Bruxelles Lambert SA
France
8.79 %
7. Amgen Inc
4.32 %
8. Exor NV
Netherlands
8.76 %
8. BioNTech SE
4.13 %
9. Creades A
Sweden
8.43 %
9. Karuna Therapeutics Inc
3.75 %
10. SEB A
Sweden
7.02 %
10. Royalty Pharma Plc
3.28 %
11. Ratos B
Sweden
4.87 %
-
12. Bure Equity AB
Sweden
4.6 %
-
13. VNV Global AB
Sweden
2.84 %
-

The list of fund holdings was last updated on April 17, 2025.